[HTML][HTML] Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …
Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis
AR Maher, M Maglione, S Bagley, M Suttorp, JH Hu… - Jama, 2011 - jamanetwork.com
Context Atypical antipsychotic medications are commonly used for off-label conditions such
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …
Psychopharmacological treatment of obsessive-compulsive disorder (OCD)
A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …
cognitive symptoms causing personal distress and reduced global functioning. These have …
[PDF][PDF] Practice guideline for the treatment of patients with obsessive-compulsive disorder
American Psychiatric Association, LM Koran… - 2007 - academia.edu
PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …
[HTML][HTML] Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
This review summarizes evidence of dysregulated reward circuitry function in a range of
neurodevelopmental and psychiatric disorders and genetic syndromes. First, the …
neurodevelopmental and psychiatric disorders and genetic syndromes. First, the …
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …
B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …
The pharmacologic treatment of anxiety disorders: a review of progress
LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …
frequently cause significant functional impairment. Both psychotherapeutic and …
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
MH Bloch, A Landeros-Weisenberger, B Kelmendi… - Molecular …, 2006 - nature.com
As many as half of obsessive-compulsive disorder (OCD) patients treated with an adequate
trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment and continue to …
trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment and continue to …
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …
treatment for anxiety disorders. They are based explicitly on the available evidence and are …
Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines
S Pallanti, L Quercioli - Progress in Neuro-Psychopharmacology and …, 2006 - Elsevier
While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-
compulsive disorder (OCD), up to 40–60% of patients do not have a satisfactory outcome …
compulsive disorder (OCD), up to 40–60% of patients do not have a satisfactory outcome …